Hitgen

The Mcl-1 Inhibitor S63845 is Tolerable and Effective in Diverse Cancer Models

The Mcl-1 Inhibitor S63845 is Tolerable and Effective in Diverse Cancer Models

Kotschy, A. et al., Nature 2016, 538, 477–482

< Back to all news
Would you like to learn more?

For further information about partnering with Vernalis, or to find out more about our capabilities or career opportunities.

bd@vernalis.com hr@vernalis.com
Contact us

Services

© 2024 Vernalis (R&D) Limited. All Rights Reserved. Web Design by Red Graphic. Web Development by Red Web.